These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4006479)

  • 1. Permeability for middle and higher molecular weight substances. Comparison between polysulfone and cuprophan dialyzers.
    Brunner H; Mann H; Stiller S; Sieberth HG
    Contrib Nephrol; 1985; 46():33-42. PubMed ID: 4006479
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Sarnecka S
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 8. The past, present and future of the dialyzer.
    Mineshima M
    Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
    Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
    Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
    [No Abstract]   [Full Text] [Related]  

  • 10. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
    Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
    Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced iopromide elimination in hemodialysis with cuprophan membranes.
    Matzkies FK; Reinecke H; Tombach B; Koeneke J; Hohage H; Kisters K; Schaefer RM
    Acta Radiol; 2000 Nov; 41(6):671-3. PubMed ID: 11092496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dialysis membranes on the convective transport of middle molecules.
    De Francisco AL; Gordillo J; Cotorruelo JG; Ruiz L; Gonzalez M; Morales P; Arias M
    Int J Artif Organs; 1986 Nov; 9(6):421-6. PubMed ID: 3818117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
    Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 16. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers.
    Lanese DM; Alfrey PS; Molitoris BA
    Kidney Int; 1989 Jun; 35(6):1409-12. PubMed ID: 2770120
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of hormones by hemofiltration and hemodialysis with a highly permeable polysulfone membrane.
    Wizemann V; Velcovsky HG; Bleyl H; Brüning S; Schütterle G
    Contrib Nephrol; 1985; 46():61-8. PubMed ID: 2408819
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Bergamo Collaborative Dialysis Study Group.
    Kidney Int; 1991 Oct; 40(4):714-9. PubMed ID: 1745022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the basic principles determining the performance of several high-flux dialyzers.
    Jindal KK; McDougall J; Woods B; Nowakowski L; Goldstein MB
    Am J Kidney Dis; 1989 Dec; 14(6):507-11. PubMed ID: 2688406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.